Sino Medical Sciences Technology Inc. (688108.SS)
CNY 10.24
(-0.49%)
CNY 10.24
(-0.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 144.49 Million CNY | 147.79% |
| 2022 | 58.31 Million CNY | 31.71% |
| 2021 | 44.27 Million CNY | -13.05% |
| 2020 | 50.91 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 954.86 Thousand CNY | -18.48% |
| 2017 | 1.17 Million CNY | 13.29% |
| 2016 | 1.03 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 269.42 Million CNY | 79.02% |
| 2024 Q1 | 150.5 Million CNY | 4.16% |
| 2024 Q3 | 107.84 Million CNY | -52.48% |
| 2023 Q4 | 144.49 Million CNY | 19.95% |
| 2023 FY | 144.49 Million CNY | 147.79% |
| 2023 Q3 | 120.45 Million CNY | 22.77% |
| 2023 Q2 | 98.11 Million CNY | 47.77% |
| 2023 Q1 | 66.39 Million CNY | 13.86% |
| 2022 Q4 | 58.31 Million CNY | -11.68% |
| 2022 Q2 | 65.92 Million CNY | 1.14% |
| 2022 Q1 | 65.18 Million CNY | 47.22% |
| 2022 Q3 | 66.02 Million CNY | 0.15% |
| 2022 FY | 58.31 Million CNY | 31.71% |
| 2021 Q2 | 50.26 Million CNY | -5.4% |
| 2021 Q1 | 53.13 Million CNY | 0.0% |
| 2021 FY | 44.27 Million CNY | -13.05% |
| 2021 Q4 | 44.27 Million CNY | -9.37% |
| 2021 Q3 | 48.85 Million CNY | -2.8% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 50.91 Million CNY | 0.0% |
| 2019 Q4 | - CNY | -100.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q3 | 1.05 Million CNY | 46.59% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 722 Thousand CNY | 0.0% |
| 2018 Q4 | 954.86 Thousand CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 954.86 Thousand CNY | -18.48% |
| 2017 FY | 1.17 Million CNY | 13.29% |
| 2016 FY | 1.03 Million CNY | 0.0% |